News

A publication by scientists of the Anticancer Fund

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys - On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology, 31 January 2020, DOI: 10.3389/fphar.2019.01664

Transparancy of clinical trial reports assured

Clinical trials should remain transparent

A publication by scientists of the Anticancer Fund

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka, Ciska Verbaanderd, Lydie Meheus - Biased by design? Clinical trials and patient benefit in oncology. Future Medicine, 16 (3), doi.org/10.2217/fon-2019-0763

Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in Belgium.

Werbrouck, J., Bouche, G., de Jonge, E., Jacomen, G., D'Hondt, V., Denys, H., Van Limbergen, E., Vandermeersch, B., De Schutter, H., Van Eycken, E., Goffin, F., & Amant, F. (2013). Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in Belgium. Gynecologic Oncology, 131(3):512-9. doi:10.1016/j.ygyno.2013.10.001